Introduction
Kidney transplantation is the best treatment for end-stage renal disease, leading to improved survival rates and quality of life. Despite advancements in managing medical complications, the incidence of surgical complication still amounts to 15.9%, including a 2.7% incidence rate of vascular complications. 1 Transplant renal vein thrombosis (TRVT) is a catastrophic vascular complication, with an incidence rate of 0.1%-3.4%,
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Hori et al resulting in allograft loss and nephrectomy in most cases. [1] [2] [3] [4] [5] [6] [7] Reportedly, TRVT may be caused by multiple factors, including recipient factors (age, pre-transplant dialysis modality, and perioperative hemodynamic status), donor factors (age, right kidney, and prolonged ischemia time), immunosuppression regimens (cyclosporine and mycophenolate mofetil [MMF] ), and surgical techniques. 2, 5, [7] [8] [9] [10] [11] Clinical presentation of TRVT is similar to that of rejection or urological complications, which are the two most frequent complications immediately after kidney transplantation. Furthermore, the findings of Doppler ultrasonography (US) are also similar to those noted in graft rejection. Thus, diagnosis of TRVT is not easy, and suspicion of TRVT is the most important tool for early diagnosis and intervention, avoiding potential allograft loss. In our case, delayed allograft function that did not improve with steroid pulse therapy was observed, and surgical exploration was performed due to suspected urological and vascular complications, including TRVT. An early decision to perform surgical exploration and an appropriate intervention could salvage allograft dysfunction induced by TRVT immediately after kidney transplantation.
Case presentation
A 41-year-old man diagnosed with end-stage renal disease, secondary to Gout kidney disease, was hospitalized for preemptive living kidney transplantation. He underwent ABOcompatible living kidney transplantation. The kidney donor was his 45-year-old sister, and her right kidney was selected for allograft due to a split renal function with Tc-99m mercaptoacetyltriglycine-3 renography revealing superiority of contralateral kidney function. The right kidney consisted of a single artery and vein. Despite instruction of weight loss, his preoperative body mass index (BMI) was 33.4 kg/m 2 ; thus, we handled the surgery with the greatest care to avoid complications. The surgery progressed smoothly (first warm ischemic time: 5 minutes, cold ischemic time: 29 minutes, and second warm ischemic time: 60 minutes), and urine output was observed immediately after reperfusion of the transplant renal artery and vein. Doppler US immediately before abdominal closure revealed sufficient blood flow throughout the allograft, without reversed or absent diastolic flow and an obvious elevated resistive index (RI). An allograft biopsy 1 hour after the allograft blood flow was restored, showing no specific changes. He was introduced to an immunosuppression regimen consisting of tacrolimus, MMF, prednisone, and basiliximab. On postoperative day (POD) 1, the serum creatinine levels decreased, the urine output gradually decreased, hematuria was recognized, and Doppler US revealed mild hydronephrosis in the allograft. Doppler US on POD 2 showed a decrease in the diastolic flow and an elevated RI without obvious evidence of TRVT ( Figure 1A) ; thus, rejection was considered, and steroid pulse therapy was initiated. Despite this therapy, allograft function did not improve, hydronephrosis worsened, and urine output decreased. Unenhanced computed tomography (CT) on POD 4 revealed a hematoma with air in the urinary tract of the allograft ( Figure 1B and C) , and serum creatinine levels increased to 7.0 mg/dL. By washing ureteral catheter to check 
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successful salvage of tRVt for obstraction was the reason why air accumulated in urinary tract. To remove the hematoma with clots in the urinary tract, a ureteral stent was placed, and the allograft was assessed for anastomotic stenosis and compression of the renal artery and vein; then, surgical exploration was performed. Perforation of the pelvis was detected, and evacuation of the hematoma with clots in the urinary tract was performed. Ureteral stent indwelling was performed, and the pelvis was repaired using bioabsorbable sutures. Vascular anastomoses were examined to determine whether there was arterial anastomotic stenosis, kinking of the artery, compression of the vein, and presence of thrombosis. Although there was no evidence of arterial anastomosis and kinks in the renal artery, one of the two branches of the proximal renal vein was compressed by the surrounding tissues, including the allograft, and TRVT was detected. Therefore, subsequent surgical thrombectomy was performed, and Doppler US revealed improved diastolic flow and RI (Figure 2A-C) . Postoperative CT also showed that hydronephrosis and the urinary tract hematoma were no longer present ( Figure 3A and B) . Simultaneously, an allograft biopsy was performed and showed no evidence of rejection, calcineurin inhibitor toxicity, or tubular injury. After surgical thrombectomy, urine output increased, and serum creatinine levels decreased to 1.8 mg/dL (Figure 4 ).
Ethical approval
Patient provided written informed consent for the publication of his case details and accompanying images. This case report was approved by the institutional review board for Clinical Studies (Medical Ethics Committee ID: NMU-1131).
Figure 2
Representative allograft image and schematic for surgical exploration. Notes: Representative image of the allograft during surgical exploration. arterial anastomotic stenosis was not observed. the proximal renal vein was branched into two, and one branch was compressed by the surrounding tissues, including the allograft, renal artery, and abdominal wall, resulting in tRVt. In addition, the upper urinary tract of the allograft was occupied by a hematoma with clots and air (A), red arrow: renal artery, blue arrow: renal vein, green arrow: allograft, and yellow arrow: ureter. a schematic of the intraoperative allograft is shown. the trunk of the renal vein had no evidence of thrombosis, and a thrombectomy was performed. In addition, a hematoma with a clot of the upper urinary tract was evacuated (B). Doppler Us showed improved end-diastolic blood velocity (11.7 cm/s) and RI (0.56) (C). Abbreviations: RI, resistive index; tRVt, transplant renal vein thrombosis; Us, ultrasonography; ps, peak systolic; eD, end-diastolic; MD, mean diastolic; taMaX, time averaged maximum; pI, pulsatility index; RI, resistance index; at, acceleration time.
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Internal iliac artery 2,12,13 Although surgical procedures proceeded smoothly, venous anastomosis was carried out gently, and the transplant vein was not too long and did not show kinking during the operation, it was difficult to confirm that there were no complications with the surgical techniques used. Retrospectively, Doppler US immediately after abdominal closure showed a very slight decrease in diastolic blood flow compared to that before the abdominal closure; this might be a sign of TRVT. Generally, the clinical presentation of TRVT is oliguria, hematuria, and a painful swollen allograft, along with allograft dysfunction as well as the Doppler US typically showing a decrease in diastolic flow and an elevated RI, which are also features of rejection. 4, 6 Although hematuria with mild hydronephrosis, a decrease in urine output without oliguria, and allograft dysfunction were observed in our case, acute rejection was suspected at first considering the findings of the Doppler US. Despite steroid pulse therapy, allograft function did not improve and, as a result, surgical exploration revealed the presence of TRVT. Repeated Doppler US also did not reach the detection of TRVT in this case. Obesity is one of the reasons. Despite the advancements in Doppler US including image resolution, some vascular complications cannot be diagnosed with Doppler US even if expert in US examination performed. 14 Diagnosing TRVT is very difficult, and suspicion of TRVT is very important for the prevention of allograft loss. In addition, unenhanced magnetic resonance angiography is an option for assessing transplant arteries and veins without damaging the allograft, including the use of contrast material; the quality of the unenhanced magnetic resonance angiography image was equivalent to that of the contrasted image. 15 Early diagnosis leads to successful salvaging of allograft function, and thus various modalities assessing the allograft, including form, surrounding tissues, the urinary tract, and renal vessels, should be used for an accurate diagnosis, followed by early intervention without hesitation.
Reportedly, TRVT can be caused by various factors, including recipient factors, donor factors, immunosuppression regimens, and surgical techniques. 2, 5, [7] [8] [9] [10] [11] Our case had at least two of these factors (right kidney and usage of MMF), and combination of these factors might result in the development of TRVT. In addition, obesity (BMI >30 kg/m 2 ) is associated with not only the development of urological complications but also the development of vascular complications including renal artery stenosis and TRVT. 16, 17 In our case, the recipient's preoperative BMI was 33.4 kg/m 2 , and the Doppler US immediately after abdominal closure showed a very slight decrease in diastolic blood flow compared to that before abdominal closure. Therefore, we retrospectively suggest that the cause of TRVT in our case is that the relatively short renal vein (due to the right kidney) was compressed by surrounding tissues, including the swelling allograft, and the compression was worsened by abdominal closure. Although obesity itself is a risk of the development of cardiovascular events and affects mortality, 18 when performing kidney transplantation in obese patients, surgeons must pay attention to the various obesity-related complications. These include not 
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successful salvage of tRVt only wound complications but also vascular complications, such as artery stenosis and TRVT. Preoperative management of obese patients, including nutritional intervention and exercise programs, could lead to a decrease in perioperative complications, resulting in good prognosis for patients. In addition, to avoid renal vein compression, the use of mesh should be considered. Reportedly, the use of mesh to prevent renal allograft compartment syndrome showed minimal risks and good overall graft and recipient survival rate. Obesity recipients should be taken into consideration to use mesh. 19 Although thrombolytic therapy and surgical thrombectomy are the most common treatments for TRVT, successful management of salvaging the allograft is often difficult, resulting in allograft loss. Harraz et al 20 investigated the outcome and factors determining the success of allograft salvage with vascular complications, including TRVT, during living kidney transplantations performed on 2,208 consecutive patients. The study showed that older patients, pre-transplant hypertension, more human leukocyte antigen mismatches, shorter ischemia time, and a longer time to be diagnosed were significantly associated with non-salvage of the allograft after vascular complications, using univariate analysis. Nevertheless, none of these variables were significant using multivariate analysis. Eleven patients out of 23 lived with a functioning graft during a median follow-up of 35 months. With regard to TRVT, 4 patients out of 23 were diagnosed with TRVT. Although three allografts were salvaged (two: thrombolytic therapy, one: surgical thrombectomy), one allograft was lost. 20 In our case, surgical thrombectomy was performed as a result of surgical exploration, resulting in a successful salvage. Considering TRVT as a cause of allograft dysfunction during surgical exploration is important for dealing with the devastating complication with adequate preparation. Repeatedly, preoperative sufficient assessments, Figure 4 Clinical course of serum creatinine levels and urine output and the immunosuppression regimen. Notes: on poD 4, the serum creatinine level was 7.0 mg/dL, and urine output decreased; thus, surgical exploration was performed. after evacuation of the transplant renal vein thrombosis and hematoma of the upper urinary tract of the allograft, serum creatinine levels decreased to 1.8 mg/dL, and urine output increased. the immunosuppression regimen was as follows: tacrolimus, MMF, psL, and BXM. at discharge, the doses of each immunosuppressive agent were as follows: 10 mg/day tacrolimus, 1,000 mg/day MMF, and 5 mg/day psL. Abbreviations: BXM, basiliximab; MMF, mycophenolate mofetil; poD, postoperative day; psL, prednisone; tac, tacrolimus. 
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Hori et al including unenhanced magnetic resonance angiography, can lead to early and accurate diagnosis and intervention, resulting in successful management of the allograft. In addition, peri-and postoperative management such as low-dose aspirin and low-molecular-weight heparin may have benefits in preventing TRVT in high-risk patients, especially in patients with hypercoagulable profiles or those who received kidneys with more than one renal artery. 21 In simultaneous pancreas and kidney transplantation, graft thrombosis is the most common cause of graft loss. The administration of heparin immediately after surgery leads to a significant reduction in graft thrombosis and graft loss. 22 In our experience, considering TRVT as a cause of allograft dysfunction can lead to early and accurate diagnosis and intervention, avoiding allograft loss. Multiple imaging modalities, including unenhanced magnetic resonance angiography, should be used without hesitation. Surgical exploration should also be considered for accurate diagnosis and treatment when the cause of allograft dysfunction is not clarified by various examinations.
Conclusion
We reported a successful salvage of TRVT immediately after kidney transplantation. Diagnosing TRVT is not easy, and suspecting TRVT using various assessment tools that are less harmful to the allograft without hesitation is important. Considering TRVT could lead to early and accurate diagnosis and intervention, avoiding allograft loss.
